FDA adds safety warnings to certain type 2 diabetes medications
Type 2 diabetes medicines that contain saxagliptin and alogliptin may increase the risk of heart failure, especially in patients who already have heart or kidney disease, according to results from an...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news
More News: Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Urology & Nephrology | Warnings